Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta2 agonist-mediated vasodilation and beta antagonism-Reference-Cited by-同舟云学术

Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta2 agonist-mediated vasodilation and beta antagonism

Published:1989-06 Issue:19 Volume:63 Page:I3-I6
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Sybertz Edmund J.,Watkins Robert W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer of labetalol;Baum;J Pharmacol Exp Ther,1981

2. Antihypertensive actions of an isomer of labetalol and other vasodilator beta-adrenoceptor blocker;Baum,1983

3. Role of beta2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol (abstract 911);Watkins,1988

4. Intrinsic beta-sympathomimetic activity of dilevalol, the R,R-isomer of labetalol;Matsunaga;J Pharmacobiodyn,1985

5. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927;Sybertz;J Pharmacol Exp Ther,1981

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with a β-blocker with β2-agonism improves glucose and lipid metabolism in essential hypertension;Metabolism;1994-04

2. Acute Hemodynamic and Neurohumoral Profile of Dilevalol in Hypertensive Patients with Ischemic Heart Disease;Journal of Cardiovascular Pharmacology;1993-08

3. Metabolic effects of carteolol and dilevalol in essential hypertension;European Journal of Clinical Pharmacology;1992-01

4. Metabolic considerations in the choice of therapy for the patient with hypertension;American Heart Journal;1991-02

5. Penbutolol and Carteolol: Two New Beta-Adrenergic Blockers with Partial Agonism;The Journal of Clinical Pharmacology;1990-05